C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/04 (2006.01) A61K 31/4025 (2006.01) A61P 9/00 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/14 (2006.01) C07D 405/06 (2006.01) C07D 409/06 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2462903
Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on- l-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin Vla receptor.
La présente invention concerne de nouveaux dérivés d'acide 2-(azetidin-2-sur-1-yl)alcanedioïque destinés au traitement de maladies sensibles à l'antagonisme du récepteur V¿la? de vasopressine.
Bruns Robert F. Jr.
Guillon Christophe D. G.
Heindel Ned D.
Koppel Gary A.
Miller Marvin J.
Azevan Pharmaceuticals Inc.
Serenix Pharmaceuticals Llc
Smart & Biggar
LandOfFree
Beta-lactamyl vasopressin v1a antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-lactamyl vasopressin v1a antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-lactamyl vasopressin v1a antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2087373